Abionic SA

The revolutionary in vitro diagnostic point-of-care platform

Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply health care professionals with a novel point-of-care diagnostic tool. Abionic therewith gives access to immediate results for various diseases, for example the fastest test for early sepsis detection.

News

22.02.2024 Startups welcome field experts in C-level roles (startupticker.ch)
13.06.2023 The Swiss Medtech Award 2023 goes to Abionic (startupticker.ch)
16.05.2018 Global visibility for Swiss startups (startupticker.ch)
20.12.2017 SEF4KMU: Die acht neuen Label-Träger 2017 (startupticker.ch)

Milestones/News

Documents

Videos and Presentations


Nicolas Durand presents Abionic (3min)



Abionic featured on French TV channel ARTE


Discover Abionic's new infrastructures at Biopôle, Switzerland and words from Dr. Nicolas Durand, CEO.


Two million Swiss francs for an allergy-detecting device (EPFL movie)


SRF/ECO: Abionic ist einen Schritt weiter


Abionic featured in the Polytech Ventures movie


See Abionic on French National TV France3 (only in French)